Skip to main content
    S

    Sarepta Therapeutics Inc (SRPT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $14.77
    -0.36 (-2.38%)

    Market Cap: $1.72B

    Last updated: Nov 17, 2026 at 4:38 PM ET

    Sarepta Therapeutics Inc (SRPT) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Sarepta Therapeutics (SRPT) has a latest price of $14.77 on Nov 17, 2026, 40.2% below its 52-week high of $24.68. Its price fell 21.5% over the past 12 months. The month-end price fell 52.5% over the 10 years through Oct 2026, a compound annual decline of 7.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $170.49 in Dec 2020 and its lowest $14.86 in Jul 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart SRPT with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SRPT.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 25.1%, and over 6 months it fell 11.2%. The month-end price fell 72.3% over the 3 years through Oct 2026, a compound annual decline of 34.8%.

    PeriodChange
    1 month-16.7%
    3 months-25.1%
    6 months-11.2%
    12 months-21.5%
    12 months, with dividends-21.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-72.3%-34.8%
    5 years-76.5%-25.1%
    10 years-52.5%-7.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 102.8%, and its weakest was 2025, when it fell 82.3%.

    YearCloseChange
    2026 through Oct 2026$18.62-13.5%
    2025$21.52-82.3%
    2024$121.59+26.1%
    2023$96.43-25.6%
    2022$129.58+43.9%
    2021$90.05-47.2%
    2020$170.49+32.1%
    2019$129.04+18.2%
    2018$109.13+96.1%
    2017$55.64+102.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 19.4% below its 50-day average of $18.32 and 20.0% below its 200-day average of $18.46.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$14.77
    52-week high$24.68-40.2%
    52-week low$14.68+0.6%
    50-day average$18.32-19.4%
    200-day average$18.46-20.0%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 92.7%.

    MeasureValue
    1-year beta1.74
    Largest fall, 1 year-38.0%
    Largest fall, 3 years-92.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About SRPT

    What is SRPT's 1-year price change?

    Sarepta Therapeutics's price fell 21.5% over the past 12 months. With dividends included, the 12-month total return was -21.5%.

    What is SRPT's 5-year price change?

    Sarepta Therapeutics's month-end price fell 76.5% over the 5 years through Oct 2026, a compound annual decline of 25.1%. These figures leave out dividends.

    What is SRPT's 52-week high and low?

    Sarepta Therapeutics's 52-week high is $24.68 and its 52-week low is $14.68. Its latest price of $14.77 on Nov 17, 2026 is 40.2% below the high.

    What is SRPT's beta?

    Sarepta Therapeutics's 1-year beta against the S&P 500 is 1.74, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 38.0%.

    Is the SRPT chart free?

    Yes. Advanced Charting for SRPT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.